Results 91 to 100 of about 3,156 (181)

Systemic clinical-grade recombinant decorin reduces disease burden and fibrosis in advanced recessive dystrophic epidermolysis bullosa. [PDF]

Mol Ther Adv
Gretzmeier C, Hang B, Sengle G, Phillips C, Buer B, Fletcher S, Belov A, Bleck G, Collins IJ, Brinckmann J, de Souza MP, Landy H, Nyström A.   +12 more
europepmc   +1 more source

A Novel Nasal Continuous Positive Airway Pressure-Assisted Approach for Airway Management in a Patient With Dystrophic Epidermolysis Bullosa: A Case Report. [PDF]

Cureus
Iwamoto T, Ishikawa S, Yoshioka K, Mutou R, Takeda Y.   +4 more
europepmc   +1 more source

A Case of Dystrophic Epidermolysis Bullosa Treated with Meek Technique and Cultured Epithelial Autografts. [PDF]

J Plast Reconstr Surg
Ito N, Komiya T, Asai M, Ayabe N, Hanano M, Aoki K, Shimada K, Matsumura H.   +7 more
europepmc   +1 more source

Tissue and systemic inflammation in dystrophic epidermolysis bullosa: a systematic review and meta-analysis. [PDF]

Orphanet J Rare Dis
Karakioulaki M, Kwarteng NA, Nikolakopoulou A, Yang H, Hess M, Binder H, Eyerich K, Has C.   +7 more
europepmc   +1 more source

Case Report: Successful treatment of dystrophic epidermolysis bullosa pruriginosa with upadacitinib in a patient with <i>COL7A1</i>, <i>CARD14</i>, and <i>G6PD</i> gene mutations. [PDF]

Front Med (Lausanne)
Li H, Zhang Y, Lin X, Yan T, Wu X, Zhang Z.   +5 more
europepmc   +1 more source

Zinc as a Biomarker of Nutritional Status and Clinical Burden in Recessive Dystrophic Epidermolysis Bullosa: Implications for Preventive Monitoring. [PDF]

Nutrients
Quintana-Castanedo L, Maseda R, Sánchez-Ramón S, Butta N, Molero-Luis M, Crespo MG, Buño A, Herráiz-Gil S, León C, Varas A, Fernández-Sevilla LM, Zuluaga P, de Lucas R, Del Río M, Vicente Á, Escámez MJ, Sacedón R.   +16 more
europepmc   +1 more source

MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics. [PDF]

Front Immunol
Maseda R, Arriba MC, Martínez-Santamaría L, Jiménez E, Herráiz-Gil S, Illera N, Quintana-Castanedo L, García M, Suárez-Sancho S, Yáñez R, Pérez-Conde I, Carretero M, Martínez-Queipo M, de Paz R, León C, Jiménez-Yuste V, Borobia AM, Vicente Á, Lwin SM, McGrath JA, Fernández-Santos ME, Butta N, Sacedón R, Del Río M, de Lucas R, Escámez MJ.   +25 more
europepmc   +1 more source

FDA approval of prademagene zamikeracel (Zevaskyn): advancing gene therapy for recessive dystrophic epidermolysis bullosa (RDEB) patients. [PDF]

Ann Med Surg (Lond)
Shahid SR, Shahid K, Khalid M, Waafira A.   +3 more
europepmc   +1 more source

Patient-reported Itch Outcome Measures for Chronic Pruritus in Dystrophic Epidermolysis Bullosa: Exploratory Analysis of a Phase 2 Randomized Controlled Trial. [PDF]

Acta Derm Venereol
Okata-Karigane U, Gorell ES, Pathmarajah P, Li S, Chiou AS.   +4 more
europepmc   +1 more source

Sephardic origins revealed for rare skin disorder, recessive dystrophic epidermolysis bullosa, in individuals carrying the unique c.6527insC mutation. [PDF]

J Med Genet
Warshauer EM, Maier PA, Runfeldt G, Fuentes I, Escamez MJ, Valinotto L, Natale M, Manzur G, Illera N, Garcia M, Del Rio M, Mencia A, Holguin A, Larcher F, Hellenthal G, Brown AR, Consuegra L, Rivera C, Nogueiro I, Tang J, Oro A, Marinkovich P, Palisson F, Titeux M, Hovnanian AA, Sprecher E, Skorecki K, Norris D, Bruckner A, Kogut I, Bilousova G, Roop D.   +31 more
europepmc   +1 more source